Tumor necrosis and >20 mitoses per 50 high-power fields can distinguish 'very high-risk' and 'highest-risk' within 'high-risk' gastric gastrointestinal stromal tumor.
作者： Jiabin Zheng , Renjie Li , Haibo Qiu , Tao Chen , Yongjian Zhou
关键词:
摘要: Aim We aimed to investigate the optimal criteria for classifying higher risk forms of gastric gastrointestinal stromal tumor (gGIST). Materials & methods A total 246 high-risk gGIST patients were enrolled. Univariate and multivariate analyses conducted determine association between clinicopathological features overall survival. Appropriate cut-off values calculated identify those at gGIST. Results Multivariate univariate revealed that necrosis mitotic counts are independent factors The value was 20. Patients with both >20 mitoses/50 high-power fields worse than either one. Conclusion Tumor indicate prognosis.
sci-hub.se 参考文章(16)
Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Jörg T. Hartmann, Daniel Pink, Jochen Schütte, Giuliano Ramadori, Peter Hohenberger, Justus Duyster, Salah‐Eddin Al‐Batran, Marcus Schlemmer, Sebastian Bauer, Eva Wardelmann, Maarit Sarlomo‐Rikala, Bengt Nilsson, Harri Sihto, Karla V. Ballman, Mika Leinonen, Ronald P. DeMatteo, Peter Reichardt, Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib Cancer. ,vol. 120, pp. 2325- 2333 ,(2014) , 10.1002/CNCR.28669
Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Jörg T. Hartmann, Daniel Pink, Jochen Schütte, Giuliano Ramadori, Peter Hohenberger, Justus Duyster, Salah-Eddin Al-Batran, Marcus Schlemmer, Sebastian Bauer, Eva Wardelmann, Maarit Sarlomo-Rikala, Bengt Nilsson, Harri Sihto, Odd R. Monge, Petri Bono, Raija Kallio, Aki Vehtari, Mika Leinonen, Thor Alvegård, Peter Reichardt, One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor JAMA. ,vol. 307, pp. 1265- 1272 ,(2012) , 10.1001/JAMA.2012.347
Wim G. Goettsch, Steffan D. Bos, Nancy Breekveldt-Postma, Mariel Casparie, Ron M.C. Herings, Pancras C.W. Hogendoorn, Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study European Journal of Cancer. ,vol. 41, pp. 2868- 2872 ,(2005) , 10.1016/J.EJCA.2005.09.009
Heikki Joensuu, Risk stratification of patients diagnosed with gastrointestinal stromal tumor Human Pathology. ,vol. 39, pp. 1411- 1419 ,(2008) , 10.1016/J.HUMPATH.2008.06.025
IGOR FRANK, MICHAEL L. BLUTE, JOHN C. CHEVILLE, CHRISTINE M. LOHSE, AMY L. WEAVER, HORST ZINCKE, An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. The Journal of Urology. ,vol. 168, pp. 2395- 2400 ,(2002) , 10.1016/S0022-5347(05)64153-5
N Hiraoka, Y Ino, S Sekine, H Tsuda, K Shimada, T Kosuge, J Zavada, M Yoshida, K Yamada, T Koyama, Y Kanai, Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation British Journal of Cancer. ,vol. 103, pp. 1057- 1065 ,(2010) , 10.1038/SJ.BJC.6605854
Marion J. Pollheimer, Peter Kornprat, Richard A. Lindtner, Lars Harbaum, Andrea Schlemmer, Peter Rehak, Cord Langner, Tumor necrosis is a new promising prognostic factor in colorectal cancer Human Pathology. ,vol. 41, pp. 1749- 1757 ,(2010) , 10.1016/J.HUMPATH.2010.04.018
Brian K. P. Goh, Pierce K. H. Chow, Wai-Ming Yap, Sittampalam M. Kesavan, In-Chin Song, Pradeep G. Paul, Boon-Swee Ooi, Yaw-Fui A. Chung, Wai-Keong Wong, Which Is the Optimal Risk Stratification System for Surgically Treated Localized Primary GIST? Comparison of Three Contemporary Prognostic Criteria in 171 Tumors and a Proposal for a Modified Armed Forces Institute of Pathology Risk Criteria Annals of Surgical Oncology. ,vol. 15, pp. 2153- 2163 ,(2008) , 10.1245/S10434-008-9969-Z
Markku Miettinen, Jerzy Lasota, Gastrointestinal stromal tumors: Pathology and prognosis at different sites Seminars in Diagnostic Pathology. ,vol. 23, pp. 70- 83 ,(2006) , 10.1053/J.SEMDP.2006.09.001
Margaret von Mehren, R. Lor Randall, Robert S. Benjamin, Sarah Boles, Marilyn M. Bui, Ephraim S. Casper, Ernest U. Conrad, Thomas F. DeLaney, Kristen N. Ganjoo, Suzanne George, Ricardo J. Gonzalez, Martin J. Heslin, John M. Kane, Joel Mayerson, Sean V. McGarry, Christian Meyer, Richard J. O’Donnell, Alberto S. Pappo, I. Benjamin Paz, John D. Pfeifer, Richard F. Riedel, Scott Schuetze, Karen D. Schupak, Herbert S. Schwartz, Brian A. Van Tine, Jeffrey D. Wayne, Mary Anne Bergman, Hema Sundar, Gastrointestinal stromal tumors, version 2.2014: Featured updates to the NCCN Guidelines Journal of The National Comprehensive Cancer Network. ,vol. 12, pp. 853- 862 ,(2014) , 10.6004/JNCCN.2014.0080